Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study in Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Apeptico Forschung und Entwicklung GmbH
ClinicalTrials.gov Identifier:
NCT01627613
First received: June 20, 2012
Last updated: August 28, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2014
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)